159 related articles for article (PubMed ID: 8246453)
41. Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma.
Srivastava BI; Wong-Staal F; Getchell JP
Cancer Res; 1986 Sep; 46(9):4756-8. PubMed ID: 3015396
[TBL] [Abstract][Full Text] [Related]
42. Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3.
Gavalchin J; Fan N; Waterbury PG; Corbett E; Faldasz BD; Peshick SM; Poiesz BJ; Papsidero L; Lane MJ
Virology; 1995 Sep; 212(1):196-203. PubMed ID: 7676629
[TBL] [Abstract][Full Text] [Related]
43. Morphological and antigenic variations of human T cell leukemia virus type I particles in human lymphocytes.
Miyauchi M; Maruyama K
J Electron Microsc (Tokyo); 1990; 39(3):145-54. PubMed ID: 2212921
[TBL] [Abstract][Full Text] [Related]
44. A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices.
Kimata JT; Kaneshiro SA; Kwock DW; Nakamura S; Kaneshiro MM; Nakamura JM
West J Med; 1989 Mar; 150(3):300-2. PubMed ID: 2735036
[TBL] [Abstract][Full Text] [Related]
45. [Human T cell lymphoma/leukemia virus type I].
Kilim Y; Danon YL
Harefuah; 1994 Dec; 127(12):543-7. PubMed ID: 7813935
[No Abstract] [Full Text] [Related]
46. [Detection of markers of the human T-cell leukemia virus in patients with T-cell lymphoma and Kaposi's sarcoma].
Parfenova TM; Morozov VA; Il'in KV; Chistiakova IA; Samsonov VA; Averina AV; Kakezaĭ IA; Bykovskiĭ AF
Mol Gen Mikrobiol Virusol; 1994; (5):13-7. PubMed ID: 7891727
[TBL] [Abstract][Full Text] [Related]
47. [Identification of HTLV-I markers in patients with hemoblastoses].
Kukaĭn RA; Nagaeva LI; Kalnberza IV; Murovska MF; Vinkele RA; Oss VP; Tkachenko TIu
Vopr Onkol; 1990; 36(1):40-5. PubMed ID: 2305561
[TBL] [Abstract][Full Text] [Related]
48. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
Coskun AK; Sutton RE
J Virol; 2005 Apr; 79(7):4150-8. PubMed ID: 15767416
[TBL] [Abstract][Full Text] [Related]
49. Differential susceptibility of human mononuclear cells to infection with HTLV-I.
Macchi B; Popovic M; Allavena P; Rossi P; Gallo RC; Bonmassar E
Int J Tissue React; 1987; 9(3):195-8. PubMed ID: 3036735
[TBL] [Abstract][Full Text] [Related]
50. An enzyme-linked immunosorbent assay for immune complex of HTLV-I.
Ishibashi K; Hanada S; Uozumi K; Otsuka M; Sakurami T; Hashimoto S
J Immunol Methods; 1989 May; 119(2):217-21. PubMed ID: 2786036
[TBL] [Abstract][Full Text] [Related]
51. Intestinal strongyloidiasis as a presenting symptom of HTLV-1-associated adult T-cell leukemia/lymphoma.
Grijsen M; van den Berk G; Hoekstra E; Terpstra W; Veldman S; Jansen J
Endoscopy; 2009; 41 Suppl 2():E271-2. PubMed ID: 19866424
[No Abstract] [Full Text] [Related]
52. Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.
Saxinger C; Gallo RC
Lab Invest; 1983 Sep; 49(3):371-7. PubMed ID: 6193334
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a monoclonal antibody reacting with a neutral glycolipid that is associated with human T-cell leukemia virus type I infection and freshly isolated adult T-cell leukemia.
Yamamoto K; Ono K; Nakahara K; Kitamura K; Yagita H; Okumura K
Cancer Res; 1988 Jun; 48(11):3148-52. PubMed ID: 2896541
[TBL] [Abstract][Full Text] [Related]
54. [Clinical usefulness of polyamino acid particle agglutination test for detection of anti-HTLV-I antibody].
Nishimura Y; Yoshiki K; Nakamitsu M; Fukuyoshi Y; Yamaguchi K; Takatsuki K; Imamura Y; Kusumoto Y
Rinsho Byori; 1995 Apr; 43(4):397-401. PubMed ID: 7739123
[TBL] [Abstract][Full Text] [Related]
55. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
Kannagi M; Kuroda MJ; Maeda Y; Harada S
Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
[TBL] [Abstract][Full Text] [Related]
56. Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients.
Carrel S; Buchegger F; Heumann D; Girardet C; Barras C; Losa G; Mach JP; von Fliedner V
J Clin Invest; 1984 Nov; 74(5):1882-5. PubMed ID: 6334103
[TBL] [Abstract][Full Text] [Related]
57. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
58. [Investigation on antibodies to human T cell leukemia virus type I in patients with primary glomerulonephritis].
Ito H; Azuma K; Ohashi T; Yasumoto Y; Uchida Y; Tokuda Y; Yamashita W; Uematsu T; Hanada S; Harada R
Fukuoka Igaku Zasshi; 1989 Jun; 80(6):368-71. PubMed ID: 2793039
[TBL] [Abstract][Full Text] [Related]
59. Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.
Benjamin D; Magrath IT; Freeman CB
J Natl Cancer Inst; 1983 Nov; 71(5):897-902. PubMed ID: 6316012
[TBL] [Abstract][Full Text] [Related]
60. Historical progress and the future of human cell culture research.
Moore GE; Minowada J
Hum Cell; 1992 Dec; 5(4):313-33. PubMed ID: 1339005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
